Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2003
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317280A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317279A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317277A2 Antifungal combination therapy
06/11/2003EP1317267A2 Compositions containing diacyltartaric salts of (e)-metanicotine
06/11/2003EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods
06/11/2003EP1317262A1 Topically applied hoof treatment composition concentrate
06/11/2003EP1317256A2 Pharmaceutical composition having modified carrier
06/11/2003EP1317252A2 Pharmaceutical composition having specific water activity
06/11/2003EP1317226A1 Treatment of human herpesviruses using hyperthermia
06/11/2003EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same
06/11/2003EP1126874B1 Multicomponent meningococcal vaccine
06/11/2003EP1066276B1 Process for the synthesis of hiv protease inhibitors
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0954325B1 Method for the specific immunoadsorption of selected pathogenic factors in the treatment of aids
06/11/2003EP0821586B1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423659A Recombinant gelatins
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423656A Lipopeptides as antibacterial agents
06/11/2003CN1423655A Novel lipopeptides as antibacterial agents
06/11/2003CN1423648A 1-(H-1,2,4-triazol-1-yl) butan-2-ol derivatives
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423561A Remedies for hepatitis C
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422866A Effective renaturation liquid of human interferon inclusion body comprising D-sorbiol and renaturation method
06/11/2003CN1422865A Effective renaturation liquid of recombinant human interon inclusion body and renaturation method
06/11/2003CN1422862A 3,6 branched manno oligose structure used as medicine and its preparation method
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422662A Medicine for treating bone and joint tuberculosis
06/11/2003CN1422656A Chinese medicinal preparation for treating liver disease
06/11/2003CN1422652A Chinese medicinal preparation for treating gynaecology disease of cervicitis
06/11/2003CN1422650A Ointment for treating various skin diseases and preparation method thereof
06/11/2003CN1422629A Feigan-Luqi powder for treating AIDS
06/11/2003CN1422621A 1-calcium phosphate-uracil medicine and preparation method
06/11/2003CN1111071C Vaccines containing saponin and sterol
06/11/2003CN1111069C Application of congeners of MIP of HHV8 for preventing and treating AIDS
06/11/2003CN1111063C Capsule for treating gonorrhoea and its preparation process
06/11/2003CN1111060C Medicine for treating viral hepatitis
06/11/2003CN1111044C Process for preparing garlic injection
06/11/2003CA2513347A1 The effect of a buffering agent on acidogenesis of plaque
06/10/2003US6576784 Antiviral agents
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576268 Biologically active fraction of vegetable melanin, process for its production and its use
06/10/2003US6576259 Sustained release formulations containing tacrolimus
06/10/2003US6576244 LT and CT in parenteral immunization methods against helicobacter infection
06/10/2003US6576243 Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
06/10/2003US6576240 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
06/10/2003US6576230 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
06/10/2003US6576224 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
06/10/2003CA2413024A1 Antipyretic preparation containing xylitol
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2190130C Thiadiazoles and their use as antipicornaviral agents
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
06/05/2003WO2003046192A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
06/05/2003WO2003046189A1 Flavivirus vaccine delivery system
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003046007A2 Treatment of micro-organism infection
06/05/2003WO2003045982A1 Antibiotics fki-9739 and process for producing the same
06/05/2003WO2003045965A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045893A1 Double esters
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045456A1 Process for coating a surface of a stent
06/05/2003WO2003045435A1 Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs
06/05/2003WO2003045414A2 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections
06/05/2003WO2003045408A1 An influenza treating pharmaceutical composition of traditional chinese medicine and method for preparation thereof
06/05/2003WO2003045407A1 A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
06/05/2003WO2003045406A1 An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045363A2 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 1798